
|Articles|February 4, 2022
Daily Medication Pearl: Tavaborole (Kerydin)
Author(s)Saro Arakelians, PharmD
Tavaborole (Kerydin) is indicated for the topical treatment of onychomycosis of the toenails.
Advertisement
Medication Pearl of the Day: Tavaborole (Kerydin)
Indication: Tavaborole (Kerydin) is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to trichophyton rubrum or trichophyton mentagrophytes.
Insight:
- Dosing: Apply tavaboroleto affected toenails once daily for 48 weeks.
- Dosage forms:Solution, 5%.
- Adverse events: Common adverse reactions occurring in ≥1% in subjects treated with tavaboroleincluded application site exfoliation, ingrown toenail, application site erythema, and application site dermatitis.
- Mechanism of action: Kerydin is an oxaborole antifungal.
- Manufacturer: Anacor Pharma
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
2
IRAKLIA Trial Shows Body Weight Doesn’t Alter Outcomes With On-Body Injector Isatuximab
3
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
4
Ribociclib Plus Fulvestrant Shows Strong PFS and OS Benefits in Patients With Invasive Lobular Carcinoma
5

















































































































































































































